Intestinal feedback signaling and satiety

Physiology and Behavior

Volumn 105, Issue 1, 2011, Pages 77-81

  Moran, Timothy H ^a   Dailey, Megan J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amylin; CCK; Ghrelin; GLP 1; Glucagon; PYY; Vagus

Indexed keywords

AMYLIN; CHOLECYSTOKININ; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY; PEPTIDE YY [3-36];

ARTICLE; FEEDBACK SYSTEM; FOOD INTAKE; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINE CELL; JEJUNUM; NONHUMAN; NUTRIENT; OBESITY; PRIORITY JOURNAL; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; SATIETY; SIGNAL TRANSDUCTION; STOMACH BYPASS; VAGUS NERVE;

ANIMALS; CHOLECYSTOKININ; FEEDBACK, PHYSIOLOGICAL; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INTESTINES; PEPTIDE YY; SATIATION;

EID: 80053457309     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.02.005     Document Type: Article

References (86)

1. Young R.C., Gibbs J., Antin J., Holt J., Smith G.P. Absence of satiety during sham feeding in the rat. J Comp Physiol Psychol 1974, 87:795-800.
2. Liebling D.S., Eisner J.D., Gibbs J., Smith G.P. Intestinal satiety in rats. J Comp Physiol Psychol 1975, 89:955-965.
3. Greenberg D., Smith G.P., Gibbs J. Intraduodenal infusions of fats elicit satiety in sham-feeding rats. Am J Physiol 1990, 259:R110-R118.
4. Phillips R.J., Powley T.L. Gastric volume rather than nutrient content inhibits food intake. Am J Physiol 1996, 271:R766-R769.
5. Mathis C., Moran T.H., Schwartz G.J. Load-sensitive rat gastric vagal afferents encode volume but not gastric nutrients. Am J Physiol 1998, 274:R280-R286.
6. Schwartz G.J., McHugh P.R., Moran T.H. Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. Am J Physiol 1993, 265:R872-R876.
7. Davison J.S., Grundy D. Modulation of single vagal efferent fibre discharge by gastrointestinal afferents in the rat. J Physiol 1978, 284:69-82.
8. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
9. Cummings D.E., Purnell J.Q., Frayo R.S., Schmidova K., Wisse B.E., Weigle D.S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50:1714-1719.
10. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
11. Faulconbridge L.F., Cummings D.E., Kaplan J.M., Grill H.J. Hyperphagic effects of brainstem ghrelin administration. Diabetes 2003, 52:2260-2265.
12. Seoane L.M., Lopez M., Tovar S., Casanueva F.F., Senaris R., Dieguez C. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 2003, 144:544-551.
13. Kinzig K.P., Scott K.A., Hyun J., Bi S., Moran T.H. Lateral ventricular ghrelin and fourth ventricular ghrelin induce similar increases in food intake and patterns of hypothalamic gene expression. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1565-R1569.
14. Banks W.A., Tschop M., Robinson S.M., Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002, 302:822-827.
15. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
16. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res 1997, 48:23-29.
17. Hashimoto H., Fujihara H., Kawasaki M., Saito T., Shibata M., Otsubo H., et al. Centrally and peripherally administered ghrelin potently inhibits water intake in rats. Endocrinology 2007, 148:1638-1647.
18. Williams D.L., Cummings D.E., Grill H.J., Kaplan J.M. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 2003, 144:2765-2767.
19. Overduin J., Frayo R.S., Grill H.J., Kaplan J.M., Cummings D.E. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 2005, 146:845-850.
20. Williams D.L., Grill H.J., Cummings D.E., Kaplan J.M. Vagotomy dissociates short- and long-term controls of circulating ghrelin. Endocrinology 2003, 144:5184-5187.
21. Spranger J., Ristow M., Otto B., Heldwein W., Tschop M., Pfeiffer A.F., et al. Post-prandial decrease of human plasma ghrelin in the absence of insulin. J Endocrinol Invest 2003, 26:RC19-RC22.
22. Degen L., Drewe J., Piccoli F., Grani K., Oesch S., Bunea R., et al. Effect of CCK-1 receptor blockade on ghrelin and PYY secretion in men. Am J Physiol Regul Integr Comp Physiol 2007, 292:R1391-R1399.
23. Brennan I.M., Otto B., Feltrin K.L., Meyer J.H., Horowitz M., Feinle-Bisset C. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men. Peptides 2007, 28:607-611.
24. McLaughlin J., Grazia Luca M., Jones M.N., D'Amato M., Dockray G.J., Thompson D.G. Fatty acid chain length determines cholecystokinin secretion and effect on human gastric motility. Gastroenterology 1999, 116:46-53.
25. Liddle R.A., Goldfine I.D., Rosen M.S., Taplitz R.A., Williams J.A. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 1985, 75:1144-1152.
26. Butler P.C., Chou J., Carter W.B., Wang Y.N., Bu B.H., Chang D., et al. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 1990, 39:752-756.
27. de Jong A., Strubbe J.H., Steffens A.B. Hypothalamic influence on insulin and glucagon release in the rat. Am J Physiol 1977, 233:E380-E388.
28. West D.B., Fey D., Woods S.C. Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. Am J Physiol 1984, 246:R776-R787.
29. Lutz T.A., Geary N., Szabady M.M., Del Prete E., Scharrer E. Amylin decreases meal size in rats. Physiol Behav 1995, 58:1197-1202.
30. Le Sauter J., Geary N. Hepatic portal glucagon infusion decreases spontaneous meal size in rats. Am J Physiol 1991, 261:R154-R161.
31. Moran T.H., Ameglio P.J., Peyton H.J., Schwartz G.J., McHugh P.R. Blockade of type A, but not type B, CCK receptors postpones satiety in rhesus monkeys. Am J Physiol 1993, 265:R620-R624.
32. Moran T.H., Ameglio P.J., Schwartz G.J., McHugh P.R. Blockade of type A, not type B, CCK receptors attenuates satiety actions of exogenous and endogenous CCK. Am J Physiol 1992, 262:R46-R50.
33. Moran T.H., Katz L.F., Plata-Salaman C.R., Schwartz G.J. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am J Physiol 1998, 274:R618-R625.
34. Bi S., Scott K.A., Kopin A.S., Moran T.H. Differential roles for cholecystokinin a receptors in energy balance in rats and mice. Endocrinology 2004, 145:3873-3880.
35. Mollet A., Gilg S., Riediger T., Lutz T.A. Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats. Physiol Behav 2004, 81:149-155.
36. Le Sauter J., Noh U., Geary N. Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats. Am J Physiol 1991, 261:R162-R165.
37. Brenner L., Yox D.P., Ritter R.C. Suppression of sham feeding by intraintestinal nutrients is not correlated with plasma cholecystokinin elevation. Am J Physiol 1993, 264:R972-R976.
38. Smith G., Jerome C., Norgren R. Afferent axons in the abdominal vagus mediate the satiety effects of cholecystokinin in rats. Am J Physiol 1985, 249:R638-R641.
39. Lutz T.A., Mollet A., Rushing P.A., Riediger T., Scharrer E. The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats. Int J Obes Relat Metab Disord 2001, 25:1005-1011.
40. Geary N., Smith G.P. Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiol Behav 1983, 31:391-394.
41. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., Fussel H.S., Polak J.M., Bloom S.R. Human distribution and release of a puatitive new gut hormone, peptide YY. Gastroenterology 1885, 89:1070-1077.
42. Lin H.C., Chey W.Y. Cholecystokinin and peptide YY are released by fat in either proximal or distal small intestine in dogs. Regul Pept 2003, 114:131-135.
43. Rudnicki M., Kuvshinoff B.W., McFadden D.W. Extrinsic neural contribution to ileal peptide YY (PYY) release. J Surg Res 1992, 52:591-595.
44. Greeley G.H., Hashimoto T., Izukura M., Gomez G., Jeng J., Hill F.L., et al. A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide-YY in the dog. Endocrinology 1989, 125:1761-1765.
45. Keire D.A., Whitelegge J.P., Souda P., Faull K.F., Bassilian S., Reidelberger R.D., et al. PYY(1-36) is the major form of PYY in rat distal small intestine: quantification using high-resolution mass spectrometry. Regul Pept 2010, 165:151-157.
46. Mentlein R., Dahms P., Grandt D., Kruger R. Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul Pept 1993, 49:133-144.
47. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., Reeve J.R. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol 2000, 279:G126-G131.
48. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418:650-654.
49. Chelikani P.K., Haver A.C., Reeve J.R., Keire D.A., Reidelberger R.D. Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats. Am J Physiol Regul Integr Comp Physiol 2006, 290:R298-R305.
50. Moran T.H., Smedh U., Kinzig K.P., Scott K.A., Knipp S., Ladenheim E.E. Peptide YY (3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 2004, 288:R384-R388.
51. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005, 1044:127-131.
52. Chelikani P.K., Haver A.C., Reidelberger R.D. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 2005, 146:879-888.
53. Elliott R.M., Morgan L.M., Tredger J.A., Deacon S., Wright J., Marks V. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993, 138:159-166.
54. Dailey M.J., Tamashiro K.L., Terrillion C.E., Moran T.H. Nutrient specific feeding and endocrine effects of jejunal infusions. Obesity (Silver Spring) 2010, 18:904-910.
55. Lejeune M.P., Westerterp K.R., Adam T.C., Luscombe-Marsh N.D., Westerterp-Plantenga M.S. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr 2006, 83:89-94.
56. Brubaker P.L., Anini Y. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol 2003, 81:1005-1012.
57. Little T.J., Doran S., Meyer J.H., Smout A.J., O'Donovan D.G., Wu K.L., et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab 2006, 291:E647-E655.
58. Ruttimann E.B., Arnold M., Hillebrand J.J., Geary N., Langhans W. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009, 150:1174-1181.
59. Chelikani P.K., Haver A.C., Reidelberger R.D. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1695-R1706.
60. Scott K.A., Moran T.H. The GLP-1 agonist exendin-4 reduces food intake in non-human primates through changes in meal size. Am J Physiol Regul Integr Comp Physiol 2007, 293:R983-R987.
61. Ruttimann E.B., Arnold M., Geary N., Langhans W. GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats. Physiol Behav 2010, 100:291-296.
62. Williams D.L., Baskin D.G., Schwartz M.W. Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety. Endocrinology 2009, 150:1680-1687.
63. Kieffer T.J., McIntosh C.H., Pederson R.A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 1995, 136:3585-3596.
64. Han V.K., Hynes M.A., Jin C., Towle A.C., Lauder J.M., Lund P.K. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain. J Neurosci Res 1986, 16:97-107.
65. Goke R., Larsen P.J., Mikkelsen J.D., Sheikh S.P. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 1995, 7:2294-2300.
66. Kinzig K.P., D'Alessio D.A., Seeley R.J. The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness. J Neurosci 2002, 22:10470-10476.
67. Kinzig K.P., D'Alessio D.A., Herman J.P., Sakai R.R., Vahl T.P., Figueiredo H.F., et al. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J Neurosci 2003, 23:6163-6170.
68. McHugh P.R., Moran T.H., Barton G.N. Satiety: a graded behavioural phenomenon regulating caloric intake. Science 1975, 190:167-169.
69. McHugh P.R., Moran T.H. Accuracy of the regulation of caloric ingestion in the rhesus monkey. Am J Physiol 1978, 235:R29-R34.
70. Shide D.J., Caballero B., Reidelberger R., Rolls B.J. Accurate energy compensation for intragastric and oral nutrients in lean males. Am J Clin Nutr 1995, 61:754-764.
71. Houpt K.A. Gastrointestinal factors in hunger and satiety. Neurosci Biobehav Rev 1982, 6:145-164.
72. Wirth J.B., McHugh P.R. Gastric distension and short-term satiety in the rhesus monkey. Am J Physiol 1983, 245:R174-R180.
73. McHugh P.R. Aspects of the control of feeding: application of quantitation in psychobiology. Johns Hopkins Med J 1979, 144:147-155.
74. McHugh P.R., Moran T.H., Wirth J.B. Postpyloric regulation of gastric emptying in rhesus monkeys. Am J Physiol 1982, 243:R408-R415.
75. Woltman T., Reidelberger R. Effects of duodenal and distal ileal infusions of glucose and oleic acid on meal patterns in rats. Am J Physiol 1995, 269:R7-R14.
76. Woltman T., Castellanos D., Reidelberger R. Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats. Am J Physiol 1995, 269:R1420-R1433.
77. Welch I.M., Sepple C.P., Read N.W. Comparisons of the effects on satiety and eating behaviour of infusion of lipid into the different regions of the small intestine. Gut 1988, 29:306-311.
78. Cox J.E., Tyler W.J., Randich A., Kelm G.R., Bharaj S.S., Jandacek R.J., et al. Suppression of food intake, body weight, and body fat by jejunal fatty acid infusions. Am J Physiol Regul Integr Comp Physiol 2000, 278:R604-R610.
79. Cox J.E., Kelm G.R., Meller S.T., Spraggins D.S., Randich A. Truncal and hepatic vagotomy reduce suppression of feeding by jejunal lipid infusions. Physiol Behav 2004, 81:29-36.
80. Cummings D.E., Weigle D.S., Frayo R.S., Breen P.A., Ma M.K., Dellinger E.P., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346:1623-1630.
81. Couce M.E., Cottam D., Esplen J., Schauer P., Burguera B. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg 2006, 16:870-878.
82. le Roux C.W., Aylwin S.J., Batterham R.L., Borg C.M., Coyle F., Prasad V., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 2006, 243:108-114.
83. Vincent R.P., le Roux C.W. The satiety hormone peptide YY as a regulator of appetite. J Clin Pathol 2008, 61:548-552.
84. le Roux C.W., Welbourn R., Werling M., Osborne A., Kokkinos A., Laurenius A., et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg 2007, 246:780-785.
85. Bose M., Machineni S., Olivan B., Teixeira J., McGinty J.J., Bawa B., et al. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring) 2010, 18:1085-1091.
86. Shin A.C., Zheng H., Townsend R.L., Sigalet D.L., Berthoud H.R. Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology 2010, 151:1588-1597.